Salax Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 15-12-2024
- Paid Up Capital ₹ 1.50 M
as on 15-12-2024
- Company Age 43 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 15-12-2024
- Satisfied Charges ₹ 1.60 M
as on 15-12-2024
- Revenue -4.47%
(FY 2018)
- Profit -29.81%
(FY 2018)
- Ebitda -6.46%
(FY 2018)
- Net Worth 4.57%
(FY 2018)
- Total Assets 20.10%
(FY 2018)
About Salax Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹2.00 M. The company has closed loans amounting to ₹1.60 M, as per Ministry of Corporate Affairs (MCA) records.
Ritesh Srivastava and Anjali Srivastava serve as directors at the Company.
- CIN/LLPIN
U24231UP1981PTC005395
- Company No.
005395
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 1981
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Salax Chemicals Private Limited offer?
Salax Chemicals Private Limited offers a wide range of products and services, including Ayurvedic Herbal Syrups & Tonics, Ayurvedic Health Tonic, Antacid Drugs, Allopathic Liver Tonic, Antispasmodic Drugs, Antispasmodic.
Who are the key members and board of directors at Salax Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritesh Srivastava  | Managing Director | 01-Aug-1997 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anjali Srivastava | Director | 01-Apr-2009 | Current |
Financial Performance of Salax Chemicals.
Salax Chemicals Private Limited, for the financial year ended 2018, experienced Minor drop in revenue, with a 4.47% decrease. The company also saw a substantial fall in profitability, with a 29.81% decrease in profit. The company's net worth moved up by a moderate rise of 4.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Salax Chemicals?
In 2018, Salax Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 09 Mar 2022 | ₹0.50 M | Open |
Uco Bank Creation Date: 23 Dec 2011 | ₹1.50 M | Open |
State Bank Of Indore Creation Date: 08 Mar 2006 | ₹0.60 M | Satisfied |
How Many Employees Work at Salax Chemicals?
Unlock and access historical data on people associated with Salax Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Salax Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salax Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
